Reports Q3 revenue $42.02B, consensus $37.6B. “Our diversified portfolio has allowed us to successfully navigate a dynamic landscape in the quarter. At the same time, we delivered on fundamentals that carry positive implications for Centene’s (CNC) multi-year earnings trajectory, including notable RFP wins, Medicare Stars improvements and ongoing operational efficiencies,” said CEO of Centene, Sarah London. “We remain confident in our full year outlook for adjusted diluted EPS of greater than $6.80 and are well positioned to capture the powerful, long-term growth opportunities we see in government-sponsored healthcare.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on CNC:
- Notable companies reporting before tomorrow’s open
- Medicare paid insurers approx $4.2B for home diagnoses, WSJ reports
- Indivior, Humana and Centene report expected settlement of antitrust litigation
- Centene (CNC) Q3 Earnings Cheat Sheet
- Notable open interest changes for October 22nd
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
